Project Concepts (Strategic Research Agreements)
Project Concepts (Strategic Research Agreements) supports investigators pursuing type 1 diabetes research, including clinical studies, to drive transformative advances in prevention, treatment, and cures.
Browse similar grants
Funder: Breakthrough T1D
Due Dates: November 5, 2026 (Round 1 LOI) | December 17, 2026 (Round 1 notification) | May 6, 2027 (Round 2 LOI) | June 17, 2027 (Round 2 notification)
Funding Amounts: Budget and duration as approved on a per-application basis
Summary: Supports research concepts aligned with Breakthrough T1D’s current Research Strategy through Strategic Research Agreements.
Key Information: An approved Letter of Intent and invitation are required before submitting a full proposal.
Description
Project Concepts is Breakthrough T1D’s semi-annual opportunity to submit Strategic Research Agreement (SRA) Letters of Intent addressing its current Research Strategy. SRAs support investigators tackling critical gaps and challenges in type 1 diabetes research. The mechanism encourages cutting-edge scientific investigation, with top priority given to concepts offering transformative breakthroughs to prevent, treat, or cure type 1 diabetes.
An SRA is a partnership between investigators and Breakthrough T1D scientists. Research plans are developed cooperatively, with regular milestone reporting and scientific interaction before and during the award. The mechanism covers single-project, multi-project, and clinical research. Clinical SRAs can support therapeutic trials and non-interventional patient-oriented studies intended to advance clinical interventions or monitoring tools for diabetes and its complications.
